| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ventyx Biosciences, Inc. Common Stock (NASDAQ: VTYX)
VTYX Technical Analysis
5
| As on 23rd Oct 2025 VTYX SHARE Price closed @ 6.60 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.36 & Strong Buy for SHORT-TERM with Stoploss of 3.50 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VTYXSHARE Price
| Open | 7.50 | Change | Price | % |
| High | 7.82 | 1 Day | 2.74 | 70.98 |
| Low | 6.55 | 1 Week | 2.95 | 80.82 |
| Close | 6.60 | 1 Month | 4.22 | 177.31 |
| Volume | 115435327 | 1 Year | 1.89 | 40.13 |
| 52 Week High 5.28 | 52 Week Low 0.84 | ||||
NASDAQ USA Most Active Stocks
| BYND | 2.84 | -20.67% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| TSLA | 448.98 | 2.28% |
| LMDX | 0.02 | 0.00% |
| INTC | 38.16 | 3.36% |
| VTYX | 6.60 | 70.98% |
| NVDA | 182.16 | 1.04% |
| AKTS | 0.04 | 0.00% |
| ADAP | 0.07 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VTYX Daily Charts |
VTYX Intraday Charts |
Whats New @ Bazaartrend |
VTYX Free Analysis |
|
|
VTYX Important Levels Intraday
| RESISTANCE | 9.05 |
| RESISTANCE | 8.26 |
| RESISTANCE | 7.78 |
| RESISTANCE | 7.29 |
| SUPPORT | 5.91 |
| SUPPORT | 5.42 |
| SUPPORT | 4.94 |
| SUPPORT | 4.15 |
VTYX Forecast October 2025
| 4th UP Forecast | 11.9 |
| 3rd UP Forecast | 10.2 |
| 2nd UP Forecast | 9.15 |
| 1st UP Forecast | 8.1 |
| 1st DOWN Forecast | 5.1 |
| 2nd DOWN Forecast | 4.05 |
| 3rd DOWN Forecast | 3 |
| 4th DOWN Forecast | 1.3 |
VTYX Weekly Forecast
| 4th UP Forecast | 9.09 |
| 3rd UP Forecast | 8.29 |
| 2nd UP Forecast | 7.80 |
| 1st UP Forecast | 7.30 |
| 1st DOWN Forecast | 5.90 |
| 2nd DOWN Forecast | 5.40 |
| 3rd DOWN Forecast | 4.91 |
| 4th DOWN Forecast | 4.11 |
VTYX Forecast2025
| 4th UP Forecast | 20.17 |
| 3rd UP Forecast | 15.82 |
| 2nd UP Forecast | 13.13 |
| 1st UP Forecast | 10.44 |
| 1st DOWN Forecast | 2.76 |
| 2nd DOWN Forecast | 0.07 |
| 3rd DOWN Forecast | -2.62 |
| 4th DOWN Forecast | -6.97 |
Ventyx Biosciences, Inc. Common Stock ( NASDAQ USA Symbol : VTYX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VTYX Business Profile
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that has completed phase I clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases. In addition, the company develops CNS-penetrant NLRP3 inhibitors. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service